Nexalin Technology Inc Warrant
NXLIW
NXLIW was delisted on the 19th of September, 2025.
8 hedge funds and large institutions have $81.2K invested in Nexalin Technology Inc Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
0.05% more ownership
Funds ownership: 10.32% → 10.37% (+0.05%)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
48% less capital invested
Capital invested by funds: $155K → $81.2K (-$73.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$588 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$81 |
| 2 |
CS
Clear Street
New York
|
-$13 |
NXLIW Hedge Fund Activity: Q1 2023 in Review
8 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology Inc Warrant (NXLIW) for Q1 2023, worth a combined $81.2K — down 48% from $155K a quarter earlier.
Fund positioning in NXLIW was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $588. The largest seller was UBS Group, cutting an estimated $81.
- 8 institutional investors held Nexalin Technology Inc Warrant (NXLIW) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $81.2K of Nexalin Technology Inc Warrant stock for Q1 2023, down 48% quarter-over-quarter.
- 0 funds opened new Nexalin Technology Inc Warrant positions in Q1 2023 and 0 closed out.
- The largest Nexalin Technology Inc Warrant buyer in Q1 2023 was Citadel Advisors, an estimated $588 added.
- The largest Nexalin Technology Inc Warrant seller in Q1 2023 was UBS Group, an estimated $81 sold.
Based on aggregated 13F filings for Q1 2023.